Biocon limited
Canmab
CANMAB contains same Drug / Molecule called “TRASTUZUMAB ”. It is a monoclonal antibody that interferes with the HER2/neu receptor. It works by targeting certain tumour cells and stopping them from growing and reproducing.These antibodies interferes with the HER2/neu receptor protein that are embedded in the cell membrane and communicate molecular signals from outside the cell (molecules called EGFs) to inside the cell, and turn genes on and off.
Indication
CANMAB is used for the treatment of Metastatic Breast Cancer
Note
nN
Precaution
CANMAB is a prescription drug and should be used under proper medical guidance and advice.
Updated On Oct 18, 2019 by AdminStrength
150 mg & 440 mg
Packing
Vial
Storage
Cold storage 2 - 8 C.
Was this page helpful?
Related Products
NATCO PHARMA LIMITED (INDIA)
Anastronat
CIPLA LTD. (INDIA)
Anastrozole-armotraz
NATCO PHARMA LIMITED (INDIA)
Xtane
CIPLA LTD. (INDIA).
Armotraz
Most Viewed Products
CIPLA LTD. (INDIA)
Abiraterone acetate-xbira
NATCO PHARMA LIMITED (INDIA)
Bendamustine-bendit
CIPLA LTD. (INDIA)
Bicalutamide-cassotide
NATCO PHARMA LIMITED (INDIA)
Bortezomib-bortenat
NATCO PHARMA LIMITED (INDIA)
Erlonat
Biocon Limited
Everolimus-evertor
NATCO PHARMA LIMITED (INDIA)
Exemestane-xtane
NATCO PHARMA LIMITED (INDIA)
Geftinat
NATCO PHARMA LIMITED (INDIA)
Glatiramer acetate-glatimer
NATCO PHARMA LIMITED (INDIA)
Ledipasvir & sofosbuvir-hepcinat lp
NATCO PHARMA LIMITED (INDIA)
Lenalidomide-lenalid
NATCO PHARMA LIMITED (INDIA)
Pomalidomide-pomalid
NATCO PHARMA LIMITED (INDIA)
Sofosbuvir & velpatasvir-velpanat
NATCO PHARMA LIMITED (INDIA)
Sorafenib-sorafenat
CIPLA LTD. (INDIA)